Technology
Synopsys (SNPS) — AI Stock Research
Put Synopsys under the microscope. Valarn runs up to 25 specialist AI analysts on SNPS — fundamentals, news, sentiment, valuation, insider activity, catalysts, and a structured bull-vs-bear debate — and shows the full reasoning behind every point, so you can reach your own view. Educational research, never buy or sell advice.
A Technology company, Synopsys gets the same multi-analyst treatment Valarn applies to sector peers such as NVIDIA, Apple, Microsoft.
Free tier · No credit card required · Results in minutes
About Synopsys
Synopsys, Inc. is a leading provider of electronic design automation (EDA) software, instrumental in the creation and validation of integrated circuits. The company offers a robust portfolio of platforms, including the Fusion Design Platform for digital implementation, and the comprehensive Verification Continuum Platform.
- Industry
- Software - Infrastructure
- Headquarters
- Sunnyvale, CA
- Exchange
- NASDAQ
- Public since
- 1992
- Employees
- 28,000
- Website
- synopsys.com
Company facts are reference information provided for context — not real-time data or investment advice.
Up to 25
AI agents per report
Up to 3
rounds of bull-vs-bear debate
100+
data sources analyzed per run
~5 min
to a full research report
From $0
free tier, no credit card
Why research Synopsys with Valarn
Most stock pages hand you a number and a rating. Valarn hands you the reasoning — the full case for and against, with every claim traceable to a source.
Depth
Up to 25 specialist AI agents examine the company from fundamentals to sentiment to insider activity — the way a fund's research desk splits the work, not one model's snap take.
Both sides
A structured debate argues the bull and the bear case across up to three rounds, so blind spots surface before you conclude anything.
Transparency
Every point links back to its source and shows its reasoning and confidence. Research you can check, not hype you have to trust.
What Valarn's analysts cover for SNPS
Every report assembles a team of AI analysts, each focused on one domain, then shows the full reasoning behind each view. Nothing here is a recommendation to buy, sell, or hold SNPS.
Market & technical context
price action, momentum, and key levels
Company fundamentals
revenue, margins, balance sheet, filings
Recent news flow
headlines, events, and how they land
Market sentiment
social, retail, and options-flow tone
Sector & peer comparison
how it stacks up against its industry
Valuation framing
multiples in context — never a price target
Upcoming catalysts
earnings dates and events to watch
Insider & institutional activity
Form 4 filings and ownership shifts
Macro backdrop
rates, inflation, and the wider environment
Bull vs. bear debate
the strongest case each way
Key risks & red flags
what could break the thesis
Final research synthesis
one clear, reasoned view with a confidence score
How Valarn researches SNPS
01
Many analysts, every angle
Valarn deploys up to 25 specialist AI agents — the exact number depends on your plan — each analyzing one slice of the company, from filings to sentiment.
02
Debate before deciding
Two AI advocates argue the bull and bear case across up to three structured rounds, surfacing risks a single answer would miss.
03
One clear, sourced thesis
A reviewer AI weighs the whole debate into a plain-language research thesis — with a confidence score and every source shown, ready in minutes.
Congressional trading in SNPS
Over the past year, STOCK Act filings disclose 4 trades in Synopsys (SNPS) by 2 members of the U.S. Congress. Latest disclosure: 2026-07-21.
4 disclosed buys · 0 disclosed sells
| Member | Ticker | Type | Amount (disclosed range) | Traded | Disclosed | Filing |
|---|---|---|---|---|---|---|
| Alan Armstrong | SNPSSynopsys Inc | Buy | $1,001 - $15,000 | 2026-03-27 | 2026-07-21 | Official |
| Ro Khanna | SNPSSynopsys Inc | Buy | $1,001 - $15,000 | 2026-06-02 | 2026-07-08 | Official |
| Ro Khanna | SNPSSynopsys Inc | Buy | $1,001 - $15,000 | 2026-05-01 | 2026-06-11 | Official |
| Ro Khanna | SNPSSynopsys Inc | Buy | $1,001 - $15,000 | 2026-04-13 | 2026-05-13 | Official |
Public STOCK Act disclosure records: amounts are self-reported ranges and filings may lag trades by up to 45 days. Shown for research and education — not investment advice, and no wrongdoing is implied.
Explore the congressional trading trackerSynopsys (SNPS) research — common questions
What does Synopsys do?
Synopsys, Inc.
Where is Synopsys headquartered?
Synopsys is headquartered in Sunnyvale, CA.
How many people does Synopsys employ?
Synopsys employs approximately 28,000 people, based on the latest available company data.
When did Synopsys go public?
Synopsys has been publicly traded since 1992.
What stock exchange is SNPS listed on?
Synopsys trades on the NASDAQ under the ticker SNPS.
What industry is Synopsys in?
Synopsys operates in the Software - Infrastructure industry within the Technology sector.
Have members of the U.S. Congress traded SNPS stock?
STOCK Act filings from the past year include 4 disclosed trades in SNPS by 2 members of Congress. Amounts are reported as ranges and filings may lag trades by up to 45 days. These are public disclosure records — educational information, not investment advice.
Is this a recommendation to buy or sell SNPS?
No. Valarn is an educational research tool. It never issues buy, sell, or hold recommendations, price targets, or performance predictions — it shows you the research so you can reach your own conclusions.
What does a Valarn report on Synopsys include?
A multi-analyst breakdown of fundamentals, news, sentiment, valuation context, insider activity, catalysts, and risks, plus a structured bull-vs-bear debate and a final synthesis — each point traceable to its source.
How much does it cost to research SNPS?
Your first report runs on the free tier with no credit card. Paid plans add more analysts, deeper debate, and more monthly reports.
How current is the research?
Valarn shows no live prices, quotes, or market data. The company details here are reference information — company-provided facts, not real-time figures — alongside what our AI analysts research on demand.
Is Valarn a financial advisor?
No. Valarn is not a registered investment adviser or broker-dealer, and nothing it produces is personalized advice. Always do your own due diligence and consult a licensed professional.
Research you can see, not hype
Valarn is an AI research tool for educational purposes only. It is not a registered investment adviser, broker-dealer, or financial planner, and its reports on Synopsys are not personalized advice or a recommendation to buy, sell, or hold any security. AI-generated content may be inaccurate or out of date — every claim links to its source so you can verify it yourself.
Educational AI research only. Not financial, investment, legal, or tax advice. Not a recommendation to buy, sell, or hold any security. AI-generated and may be inaccurate or out of date. Consult a licensed advisor.
How every Valarn report is built
The research process a hedge fund runs, simulated by AI agents
Work is split across specialist agents, argued out between a bull and a bear, then stress-tested by a risk committee before a single research view is produced — up to 25 agents on Pro+. Educational research only; we don't manage money or place trades.
- Data validation
- Specialist agents
- Bull vs bear debate
- Risk committee
- Final research view
Get an AI research report on Synopsys
Your first SNPS report is free — no credit card, results in minutes.
Compare SNPS with peers
Popular stocks
Logos are the property of their respective owners and are shown for identification only. Synopsys is not affiliated with, and does not endorse, Valarn.